Lupin, Serono to sign $1.5 billion pact for drugs
According to sources, Lupin and Merck Serono will sign pact for drugs worth $1.5 billion. The deal will include manufacturing and marketing of drugs by Lupin in emerging markets and rest of the world while Serono will retain the marketing rights of the drugs in developed nations.
Other Corporate Videos
TCS screening candidates for C-suite rejig ahead; COO, CTO posts to be filled soon
Unicorn ed-tech firm Byju's lays off at least 1,000 more employees across various functions
Tata Trusts appoints Siddharth Sharma as CEO, Aparna Uppaluri as COO
Government to release standards for checking fake reviews on e-commerce, other platforms
Reliance retail, Adani group companies among bidders for Future Retail
